Interacting Drugs |
Ketoconazole (systemic) vs Iloperidone |
Security Level |
 |
Mechanism |
Iloperidone: CYP3A4 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolites P88 and P95 may be increased. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Iloperidone. |
Management |
Reduce iloperidone dose by half when administered with a strong CYP3A4 inhibitor. |
Ketoconazole (systemic) vs Iloperidone
Post Review about Ketoconazole (systemic) vs Iloperidone Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Iloperidone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.